
April 2025 — CDMO Opportunities And Threats Report
Contractor BioPharma Company Event Product Relationship POTENTIALLY POSITIVE AbbVie Inc Novartis Pharmaceuticals Corp FDA approval of the drug to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease …